Connect with us


Bose Olubo Offers Free Medical Test As Her Amazon Nature Clinic Kick Starts



Wife of Juju music legend, Sunday Adegeye, popular known as King Sunny Ade, Dr Bose Olubo Adegeye has gone public with her new medicine practice, as her
Amazon Nature Clinic officially  took off on Nigeria’s Independence day, Friday 1st of October.
Dr Adegeye had in a statement made available to The page News thanked God for the official opening of her clinic where she said test for  Sugar,  blood pressure reading, full body analysis among others  will be conducted with  free consultation for the rest of the year.
Urging the public to take advantage of the development,  Adegeye said ”we have two medical Consultants standing by to give you the best of Medical Care. Home service is also available for the Quantum Analyser and calls could be directed to 08036569984
She has fixed the Official Opening  of the clinic for a yet to be mentioned time next year.
Meanwhile, the actor cum musician had in a recent interview with ThePageNews said her medical engagement would not terminate her musical career.
The Interview:
Actor and musician Bose Olubo Adegeye is now a medical Doctor. In this short interview with ThepageNews, Dr Adegeye explains the new experience.
Q: What happens to your music career now that you have become a medical Doctor.
A: Hmmmm, I give glory to God for making me a Vessel, once a musician is ever a musician, the only thing is that I will not be running any permanent band.
Surely I will still perform and
I will surely continue to make albums
Q: When did you begin to nurse the idea to becoming a medical doctor
A: I have always wanted to be a medical doctor and a singer
Some people still call me small nurse, because my first call to duty was school of Nursing after losing admission to University of ibadan in
1989, with a good result. I was very sad and angry, my mother is a nurse, so she encouraged me to go into nursing, which I did but later changed my mind and decided to read Computer science at Yaba College of Tech.
Q: What area of medicine are u involved
A: General Practice
Q: How is the new terrain, compared with the entertainment field.
A: Laugh…
Haà, its a different ball game.
Entertainment is art.
There is little rudiment and lots of innovations, ideas, creativities BUT in Medicine, you have to follow nature or scientific proves, everything must be proven, you have to be 99% sure.
In Medicine, you have to be accurate and sure
You have to consider Toxicity as much as you consider eficacy.
Q: What inspired the choice of your new career
A:My greatest fair from childhood is sickness.
I remember when I went to Efon Kingdom, whenever I am sick, I will call people to stay around me, I will be so scared, same as when I know anyone sick, I will stay with them untill my grandmother calls
I love to care for people, I love knowledge, my reasons.
Q:When are you taking off fully with the new work. And how do you intend to make the difference.
A: By the grace of God, the Clinic will open officially next year.

See also  Unveiled: Mystro, The Silent Worker Behind Trending Global Musicians
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Merck Asks US FDA To Authorize Promising Anti-COVID Pill




Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic.




If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat COVID-19. All other FDA-backed treatments against the disease require an IV or injection.





An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals and helping to curb outbreaks in poorer countries with weak health care systems. It would also bolster the two-pronged approach to the pandemic: treatment, by way of medication, and prevention, primarily through vaccinations.



The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.

Merck and its partner Ridgeback Biotherapeutic said they specifically asked the agency to grant emergency use for adults with mild-to-moderate COVID-19 who are at risk for severe disease or hospitalization. That is roughly the way COVID-19 infusion drugs are used.



“The value here is that it’s a pill so you don’t have to deal with the infusion centers and all the factors around that,” said Dr. Nicholas Kartsonis, a senior vice president with Merck’s infectious disease unit. “I think it’s a very powerful tool to add to the toolbox.”




The company reported earlier this month that the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

See also  Striking Resident Doctors Reject FG's New MoU




Side effects were similar between patients who got the drug and those in a testing group who received a dummy pill. But Merck has not publicly detailed the types of problems reported, which will be a key part of the FDA’s review.





Top U.S. health officials continue to push vaccinations as the best way to protect against COVID-19.




“It’s much, much better to prevent yourself from getting infected than to have to treat an infection,” Dr. Anthony Fauci said while discussing Merck’s drug last week.



Still, some 68 million eligible Americans remain unvaccinated, underscoring the need for effective drugs to control future waves of infection.




Since the beginning of the pandemic, health experts have stressed the need for a convenient pill. The goal is for something similar to Tamiflu, the 20-year-old flu medication that shortens the illness by a day or two and blunts the severity of symptoms like fever, cough and stuffy nose.




Three FDA-authorized antibody drugs have proved highly effective at reducing COVID-19 deaths, but they are expensive, hard to produce and require specialty equipment and health professionals to deliver.




Assuming FDA authorization, the U.S. government has agreed to buy enough of the pills to treat 1.7 million people, at a price of roughly $700 for each course of treatment. That’s less than half the price of the antibody drugs purchased by the U.S. government — over $2,000 per infusion — but still more expensive than many antiviral pills for other conditions.

See also  Unveiled: Mystro, The Silent Worker Behind Trending Global Musicians




Merck’s Kartsonis said in an interview that the $700 figure does not represent the final price for the medication.




“We set that price before we had any data, so that’s just one contract,” Kartsonis said. “Obviously we’re going to be responsible about this and make this drug as accessible to as many people around the world as we can.”




Kenilworth, New Jersey-based Merck has said it is in purchase talks with governments around the world and will use a sliding price scale based on each country’s economic means. Also, the company has signed licensing deals with several Indian generic drugmakers to produce low-cost versions of the drug for lower-income countries.




Several other companies, including Pfizer and Roche, are studying similar drugs and are expected to report results in the coming weeks and months. AstraZeneca is also seeking FDA authorization for a long-acting antibody drug intended to provide months of protection for patients who have immune-system disorders and do not adequately respond to vaccination.



Eventually some experts predict various COVID-19 therapies will be prescribed in combination to better protect against the worst effects of the virus.





Continue Reading


Pfizer Asks US To Allow COVID Shots For Kids Ages 5 to 11




Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 — and if regulators agree, shots could begin within a matter of weeks.



Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities.



Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration.




Now the FDA will have to decide if there’s enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26.



One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody levels just as strong as teens and young adults get from regular-strength shots.



While kids are at lower risk of severe illness or death than older people, COVID-19 does sometimes kill children and cases in youngsters have skyrocketed as the extra-contagious delta variant has swept through the country




“It makes me very happy that I am helping other kids get the vaccine,” said Sebastian Prybol, 8, of Raleigh, North Carolina. He is enrolled in Pfizer’s study at Duke University and doesn’t yet know if he received the vaccine or dummy shots.

See also  Please Come To Shikemi's Rescue!




“We do want to make sure that it is absolutely safe for them,” said Sebastian’s mother, Britni Prybol. But she said she will be “overjoyed” if the FDA clears the vaccine.




Pfizer studied the lower dose in 2,268 volunteers ages 5 to 11, and has said there were no serious side effects. The study isn’t large enough to detect any extremely rare side effects, such as the heart inflammation that sometimes occurs after the second dose of the regular-strength vaccine, mostly in young men.



If the FDA authorizes emergency use of the kid-sized doses, there’s another hurdle before vaccinations in this age group can begin. Advisers to the Centers for Disease Control and Prevention will decide whether to recommend the shots for youngsters, and the CDC will make a final decision.



To avoid dosing mix-ups, Pfizer is planning to ship vials specially marked for pediatric use containing the lower dose.




Emma H. Tobin 

Continue Reading


Doctors Without Borders Spends N17.7b On Vulnerable Nigerians -Official




The Head of Mission, Doctors without Boarder, Mr Syed Tirima has said that the not-for-profit organisation has expended N17.7billion on humanitarian services to vulnerable Nigerians.



Speaking during a visit to the Minister of Police Affairs,Alhaji Maigari Dingyadi, Tirima revealed that the group has been around since 1996, rendering medical support to all the geopolitical zones of the country.



According to a statement on Friday by the ministry spokesman, Bolaji Kazeem, titled, ‘Dingyadi canvasses medical support for police,’ Tirima enumerated some of the group’s activities to include free medical services to pediatrics, maternity interventions, primary health care for displaced persons, medical care for lassa fever patients, provision of clinical equipment to some hospitals, and food/nutritional support as well as support to the ministry of health through the provision of response services, especially during the COVID-19 outbreak.




In his response, the Minister of Police Affairs, Dingyadi sought medical support for police officers and their children from the Doctors without Borders/Medecins Sans Frontieres to enable them to discharge their duty efficiently.



The minister stated that the police are vulnerable people who had lost many officers in the course of protecting the citizens and needed the support of everybody, including Doctors without Borders.




“I believe that you are aware that the police are one of the most vulnerable security services in the country. We have lost so many and many officers had been affected with injury. As partners in progress, we do hope you can extend some of the services to police hospitals in the country,” the minister reportedly stated.

See also  Unveiled: Mystro, The Silent Worker Behind Trending Global Musicians




He recalled the activities of the group while he was the Permanent Secretary of the Ministry of Health in Sokoto state years back, and thanked the organization for promoting local content through the employment of over 90 per cent of Nigerians as staff of the organisation.

Continue Reading